Skip to content

HFNC for Induction During Bariatric Surgery Patients.

Study Protocol for the Use of High Flow Nasal Oxygen During the Anesthesia Induction and Weaning in Patients Scheduled for Bariatric Surgery. A Randomized Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03155711
Enrollment
64
Registered
2017-05-16
Start date
2017-05-05
Completion date
2017-12-30
Last updated
2018-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Collapse

Brief summary

This study aims to compared the effects of high flow nasal during the induction and during the weaning of anesthesia on intraoperative and postoperative oxygenation and postoperative atelectasis in obese patients undergoing bariatric surgery versus the standard of care, which consists in supplemental oxygen with face mask (Venturi mask).

Interventions

PROCEDUREHFNC group

Positive pressure plus supplemental oxygen through a high flow nasal oxygen device

Supplemental oxygen through venturi mask

Sponsors

Fundación para la Investigación del Hospital Clínico de Valencia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Body mass index \> 35 Kg/m2 * Bariatric surgery * Informed consent signed

Exclusion criteria

* age \<18yr or \>80yr * pregnancy or breast-feeding status * patients with previous known respiratory disease * hemodynamic instability at entry (need of vasopressors or ionotropes at entry or a ventricular assist device

Design outcomes

Primary

MeasureTime frameDescription
OxygenationintraoperativeThe oxygenation (the ratio of partial pressure of arterial oxygen with inspiratory oxygen fraction, PaO2/FIO2) informs of the percentadge of shunt.

Secondary

MeasureTime frameDescription
OxygenationFirst 24 postoperative hoursPaO2/FIO2
AtelectasisFirst 24 postoperative hoursAtelectasis evaluated with X-ray

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026